News
New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular dystrophy (DMD). In preclinical DMD mouse models, investigators demonstrated ...
Market 32 and Price Chopper have announced the launch of an in-store fundraising campaign to support the Muscular Dystrophy ...
New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular dystrophy (DMD). In ...
Market 32 and Price Chopper have announced the launch of an in-store fundraising campaign to support the Muscular Dystrophy ...
8d
NEWS10 ABC on MSNMarket 32/Price Chopper launches fundraising campaign for Muscular Dystrophy AssociationMarket 32 and Price Chopper have launched a fundraising campaign to support the Muscular Dystrophy Association (MDA).
Todo por Antonio, or ‘All for Antonio’ is a benefit festival organised by his family, a boy with congenital muscular ...
Panelists discuss how exciting ongoing research efforts are expanding similar gene therapy technologies to other muscular ...
17h
The Print on MSNHow a disabled lawyer’s 2020 jail ordeal led to SC directing TN to uphold rights of prisoners like himThe judgment followed a plea by a lawyer suffering from Becker Muscular Dystrophy, who said the prison lacked ...
Capricor’s BLA for Deramiocel was granted Priority Review in March 2025 and was supported by data from the HOPE-2 trial, its open-label extension (OLE), and natural history comparisons from FDA-funded ...
TAS-205 showed no significant impact on motor function in patients with Duchenne muscular dystrophy (DMD), highlighting the ongoing search for effective treatments for the rare condition.
After a decade-long search for answers to her difficulties with walking and other physical activities, Joanne Dalessandro of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results